Navigation Links
Medical research is essential to improving the economy and bettering lives
Date:5/6/2008

Washington, DC (Monday, May 5, 2008) Health care in the United States is expensive, but its funding is crucial because it also is a major contributor to the economy and can better lives, according to an essay appearing in the June 2008 issue of the Journal of the American Society Nephrology (JASN). Because of the cost of health care, this is not time to shrink the budget at the National Institutes of Health, which funds medical research that leads to potentially curative therapy.

As the US population increases, health care costs are sure to rise. To help stem rising health care costs, government officials are taking money away from Medicare and Medicaid programs, and budget planners are reducing the funds used to support medical science. But experts question this strategy, noting that health care employs a large segment of the national workforce (and is, therefore, a fundamental feature of the economy) and medical research is a critical enterprise that over the long run will provide more affordable health careso called high technology, as Lewis Thomas once phrased it.

Dr. Eric Neilson, Editor-in-Chief of the Journal of the American Society Nephrology and Chair of the Department of Medicine at the Vanderbilt University School of Medicine in Nashville, TN, addresses these concerns in JASN, pointing to clear examples of how investments in health care and medical research can pay off. He notes that the human papillomavirus vaccine, the antibiotic elimination of H. pyloriinduced peptic ulcer disease, and the all-trans-retinoic acid cure of promyelocytic leukemia are all cost-effective advances that have improved lives and lowered costs. Of course, these advances took years to achieve, and long-term robust funding of research was necessary for their potential to be realized.

Dr. Neilson admits that many aspects of health care are not cost-effectivefor example, the sluggish economic productivity of the doctor-patient relationship is a chronic problemthe so called Baumols curse. A number of other factors interfere with medicines productivity, including resistance to standardization, wasteful administration related to insurance reimbursement, unnecessary expenses created in the setting of medical uncertainty or futility, failure to embrace the hospice movement for end-of-life care, for-profit commercialism, and failure to provide good quality at a lower cost. Also, because of a perceived shortage of physicians and nurses, the growing cost of labor will continue to plague health care. It is not the number of physicians, however, but their professional spending habits that will increasingly take center stage in whatever happens next. Physicians can work to lower these costs in the short-run but need to identify other solutions.

Over time, more and better research can help to counteract these expenses while benefiting the human condition. The one immediate thing we can do now is maintaining our link to science. It is the discovery ground for future advances in high technology, writes Dr. Neilson. As a hedge against growing health care costs, the funding of science is priceless.


'/>"/>

Contact: Shari Leventhal
sleventhal@asn-online.org
202-416-0658
American Society of Nephrology
Source:Eurekalert  

Related medicine news :

1. KePROs Chief Medical Officer to Deliver Clinical Keynote Address
2. ABQAURP Hosts Third Annual Medical Management Conference in Orlando
3. Warren F. Muth, MD, to Serve as President of Ohio State Medical Association
4. BioForm Medical Announces Extension of Lock-Up Period
5. Federation of State Medical Boards Takes Interim Steps Toward Maintenance of Licensure Model Policy
6. Lombard Makes Investment in The Medical City, a Leading Philippine Hospital and Healthcare Provider
7. Game-Based Technology to Meet Demand for Improved Medical Teaching and Training
8. New Medical Technology is Changing the Face of Wrinkle Treatment
9. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
10. China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits
11. Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medical research is essential to improving the economy and bettering lives
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: